Rievent · Enduring Material
Advancing Equity in Relapsed/Refractory Multiple Myeloma: Integrating Emerging CELMoD Therapies Into Community Oncology Practice
This activity will review the role of CELMoD therapies in the management of R/R multiple myeloma and solutions to overcome care barriers in community settings.